Rationale for localized injection of botulinum toxin type A in spasticity

M. K. Childers, M. F. Brin

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Injection of botulinum toxin A at the neuromuscular junction may be used to target therapy for spasticity. There have been recent studies in both humans and animals on the quantification of focal paralysis, the location of fibre atrophy and its relationship to the dose, the quantification of muscular paralysis in living subjects and the relationship between clinical effects and different botulinum toxin injection sites. Although botulinum toxin A effects in dogs are potentiated by injection at the motor end-plate, the clinical benefit of this observation has get to be demonstrated.

Original languageEnglish
Pages (from-to)S37-S40
JournalEuropean Journal of Neurology
Issue numberSUPPL.2
StatePublished - 1997
Externally publishedYes


  • Botulinum toxin
  • Dose
  • Focal paralysis
  • Injection sites
  • Spasticity


Dive into the research topics of 'Rationale for localized injection of botulinum toxin type A in spasticity'. Together they form a unique fingerprint.

Cite this